ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

LPTX Leap Therapeutics Inc

3,17
-0,10 (-3,06%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Leap Therapeutics Inc LPTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,10 -3,06% 3,17 22:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,31 3,05 3,35 3,17 3,27
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.4.202414:30PRNUSLeap Therapeutics Announces $40 Million Private Placement
18.3.202412:00PRNUSLeap Therapeutics Reports Fourth Quarter and Full Year 2023..
01.2.202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
23.1.202423:28EDGAR2Form 8-K - Current report
16.1.202423:10EDGAR2Form 8-K - Current report
16.1.202423:05PRNUSLeap Therapeutics to Present New Clinical Data from Part A..
03.1.202413:00PRNUSLeap Therapeutics to Participate at the 42nd Annual J.P...
02.1.202413:00PRNUSLeap Therapeutics Announces Completion of Enrollment in..
12.12.202322:02EDGAR2Form 8-K - Current report
11.12.202322:05PRNUSLeap Therapeutics to Present New Data from Part A of the..
21.11.202313:00PRNUSLeap Therapeutics to Participate at Piper Sandler 35th..
13.11.202313:10EDGAR2Form 8-K - Current report
13.11.202313:00PRNUSLeap Therapeutics Reports Third Quarter 2023 Financial..
13.11.202312:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.9.202320:44EDGAR2Form 8-K - Current report
05.9.202313:00PRNUSLeap Therapeutics to Participate at Upcoming Investor..
30.8.202322:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
25.8.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202313:10EDGAR2Form 8-K - Current report
14.8.202313:00PRNUSLeap Therapeutics Reports Second Quarter 2023 Financial..
14.8.202312:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12.7.202313:10EDGAR2Form 8-K - Current report
12.7.202313:00PRNUSLeap Therapeutics Announces Initiation of Randomized..
20.6.202318:30PRNUSLeap Therapeutics Announces Reverse Stock Split
25.5.202323:10PRNUSLeap Therapeutics to Present Updated Data from Part A of the..
15.5.202313:00PRNUSLeap Therapeutics Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock